Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasmActive, not recruitingPhase 22026-09-03NCT03824483

4 results · Page 1 of 1

Swipe the table sideways for more columns.

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Massachusetts General Hospital (Data Collection and Specimen Analysis)BostonUnited States1
Memorial Sloan Kettering at Basking RidgeBasking RidgeUnited States9
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
Memorial Sloan Kettering CommackCommackUnited States189
Memorial Sloan Kettering MonmouthMiddletownUnited States206
Memorial Sloan Kettering NassauUniondaleUnited States193
Memorial Sloan Kettering WestchesterEast White PlainsUnited States24
Northwestern UniversityEvanstonUnited States53